Agenda Speaker

Lunchtime seminar Professor Magnus Boman, Royal Artificial intelligence (AI) in Room Vilhena−Wignacourt Institute of Technology (KTH) and Research Institutes of Sweden (RISE), epidemiology: a reality in 2018? 23 November 2018 Stockholm, Sweden Algorithm-based machine learning that leads to the generation of new knowledge and that can be applied to autonomous deci- 12:40–14:30 Magnus Boman is a professor in Intelligent Soft- sion making/problem-solving is at the core of artificial intel- ware Services and an expert in artificial intelli- ligence (AI). The opportunities and dangers posed by AI have gence, data science and statistical learning theory. He is currently fascinated humans for a long time. The beginnings of AI as Artificial intelligence (AI) in epidemiology: building learning machines for analysing patient behaviour in a science date back to the mid-1950s, and already 50 years ago a reality in 2018? clinical flow of Internet-based psychiatry patients. Over the last Stanley Kubrick and Arthur C. Clarke’s movie ‘2001: A Space dozen or so years, Magnus worked as a computational epide- Odyssey’ featured an impressive character: the malicious HAL miologist in Sweden and the United Arab Emirates, chiefly with 9000, an AI that is programmed to flexibly oversee the space- influenza-like illnesses. He spent 4 years as a foresighter for the ship and interact with its crew but that eventually gets out of 12:40 – 12:50 Arrival of participants European Commission, where he analysed the role of information control. HAL has become a symbol for the power and dangers of technology cross-industry and over many areas, including active AI. However, this is just one part of the picture. Major advances Please collect your lunch from outside the seminar room and healthy ageing and precision medicine. through AI such as an early warning system for sepsis, an join us for the talk at 12:50 automated CT scan reader, and a superhuman-quality referral decision procedure for different eye diseases etc., exemplify 12:50 – 13:00 Welcome notes Dr Ines Steffens, Moderator the great potential of its application to help overcome societal and economic challenges. At the same time, a number of tech- Dr Ines Steffens, editor-in-chief, Eurosurveillance Since April 2011, Ines has been editor-in-chief of nological, ethical, legal and socio-economic aspects need to the scientific journal Eurosurveillance published be considered in the use of AI and there is a need for rules and regulations. 13:00 – 13:50 by the European Centre for Disease Prevention and Artificial intelligence (AI) in epidemiology: Control (ECDC) in Stockholm, Sweden. She has a reality in 2018? been affiliated with the journal since 2003. During In Europe, the European Commission has put AI high on its her tenure as managing editor from 2006 to 2011, she was respon- agenda and stressed that ‘to build robust models at the core Professor Magnus Boman, Royal Institute of Technology (KTH) and sible for the transfer of the journal from its previous publishers in of AI-based systems, high quality data are a key factor to Research Institutes of Sweden (RISE), Stockholm, Sweden London and Paris to ECDC. Building up a new editorial structure improve performances’. To allow for innovation and to support and team in Stockholm, she initiated and implemented impor- the development of new technologies, revised rules on public 13:50 – 14:30 Expert panel discussion tant changes in the editorial policy and workflows. Coupled with sector information, as well as research and health data have a highly proactive approach, this led to increased visibility and been proposed to improve data sharing and open up more Questions and answers acceptance of the journal and the firm placing of Eurosurveillance data for re-use while also taking into account the interpret- among the world’s leading journals in its field. ability and transparency which are needed to avoid AI systems becoming black boxes. The 7th Eurosurveillance scientific Over 10 years, Ines was part of the Scientific Committee of the lunchtime seminar, moderated by Dr Ines Steffens, editor-in- European Scientific Conference on Applied Infectious Disease chief of the journal, will feature a keynote lecture by Professor Epidemiology (ESCAIDE). She is a member and vice-president of Magnus Boman, from the Royal Institute of Technology (KTH) the European Association of Science Editors (EASE) Council and and Research Institutes of Sweden (RISE), Stockholm, Sweden. a member of the scientific committee organising the 2020 EASE Professor Boman will introduce general concepts related to AI conference. Dr Steffens was among the group that founded the and illustrate related opportunities and challenges. He will also EASE Gender Policy Committee and she was involved in estab- present existing and possible future AI applications in commu- lishing the Sex and Gender Equity in Research (SAGER) guidelines. nicable disease epidemiology. The lecture will be followed by a panel discussion with epidemiologists and public health microbiologists. There will be room for our audience to take an active part in the discussion by sharing their experiences and expressing views. About us

Eurosurveillance is a European peer-reviewed scientific journal Eurosurveillance was founded in 1995 when a first pilot issue was devoted to the epidemiology, surveillance, prevention and control published. The journal was jointly funded until March 2007 by the of communicable diseases, with a focus on such topics that are European Commission, the Institut de Veille Sanitaire (InVS, now of relevance to Europe. It is a weekly online journal, with 50 Santé publique France) in Paris, France and the Health Protection issues per year published on Thursdays, and features short rapid Agency (HPA, now Public Health England) in London, United Kingdom. communications, longer in-depth research articles, surveillance Eurosurveillance is a registered trademark of the European Union (EU). and outbreak reports, reviews and perspective papers, as well as short news items. Timely publication of short authoritative papers Since March 2007, Eurosurveillance has been published by the Euro- on ongoing outbreaks or other relevant public health events is one pean Centre for Disease Prevention and Control (ECDC) in Stockholm, of the major assets of the journal. Under special circumstances Sweden. ECDC funds this journal with its own resources; Eurosurveil- when current events need to be urgently communicated to readers lance does not have any other sources of funding. for rapid public health action, e-alerts can be released outside of the regular publishing schedule. Topical compilations of selected The publisher grants editorial independence to the editorial team. The articles and special issues are also published in print with a views expressed in the journal are those of the authors and may not limited number of copies. necessarily comply with ECDC policy. As a non-profit publication, the journal has no financial conflicts of interest. The entire content is , free of charge for both readers and authors. All articles are indexed in the PubMed/MEDLINE, Editorial team PubMed Central (PMC), , EMBASE, EBSCO and Science [email protected] Central databases. Eurosurveillance is listed in the Directory of Open Access Journals (DOAJ) as green open access. Furthermore, Editor-in-chief it is listed in the Sherpa/Romeo database as a journal that allows Ines Steffens pre- and post-print archiving. It thus complies with the open Senior editor access standards required by international and national funders Kathrin Hagmaier such as the European Commission (FP7 and Horizon 2020), the World Health Organization, the World Bank and the Wellcome Scientific editors Trust. Karen Wilson Janelle Sandberg Seventh scientific seminar The journal has been selected for coverage by Thomson Reuters Favelle Lamb Artificial intelligence (AI) in epidemiology: and is indexed and abstracted in the Science Citation Index Assistant editors a reality in 2018? Expanded and in the Journal Citation Reports/Science Edition Alina Buzdugan beginning with volume 14(1) 2009. The most recent impact Tracy Stefanucci factor, for the year 2017, is 7.1 (Journal Citation Reports, Thomson Reuters, 2018). This places Eurosurveillance at rank 5 among the ESCAIDE 88 journals in the category Infectious Diseases. The Scopus- Contact based SCImago Journal Rank (SJR) for 2017 ranks Eurosurveillance Saint Julian’s, Malta Eurosurveillance editorial team 58 of 2,863 journals in the category Medicine (miscellaneous). 23 November 2018 The journal is also in the first quarter (Q1) in the categories Epide- European Centre for Disease Prevention and Control (ECDC) miology, Public Health, Environmental and Occupational Health and Virology. metrics in 2017 listed Eurosurveil- Postal address: ECDC, Gustav III:s Boulevard 40 lance at ranks 5 and 13 among journals in the categories Epidemi- 16973 Solna, Sweden ology and Communicable Diseases, respectively. Tel. +46 (0)8 58 60 10 00 Fax +46 (0)8 58 60 10 01 www.eurosurveillance.org www.eurosurveillance.org @eurosurveillanc Follow us on Twitter: eurosurveillanc